Weiser D - Search Results

1

Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.

Schulz HU, Schürer M, Bässler D, Weiser D. Schulz HU, et al. Among authors: weiser d. Arzneimittelforschung. 2005;55(10):561-8. doi: 10.1055/s-0031-1296905. Arzneimittelforschung. 2005. PMID: 16294501 Clinical Trial.

2

Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.

Schulz HU, Schürer M, Bässler D, Weiser D. Schulz HU, et al. Among authors: weiser d. Arzneimittelforschung. 2005;55(1):15-22. doi: 10.1055/s-0031-1296820. Arzneimittelforschung. 2005. PMID: 15727160 Clinical Trial.

3

Investigation of the effect on photosensitivity following multiple oral dosing of two different hypericum extracts in healthy men.

Schulz HU, Schürer M, Bässler D, Weiser D. Schulz HU, et al. Among authors: weiser d. Arzneimittelforschung. 2006;56(3):212-21. doi: 10.1055/s-0031-1296713. Arzneimittelforschung. 2006. PMID: 16618014 Clinical Trial.

4

Biochemical activities of extracts from Hypericum perforatum L. 5th communication: dopamine-beta-hydroxylase-product quantification by HPLC and inhibition by hypericins and flavonoids.

Denke A, Schempp H, Weiser D, Elstner EF. Denke A, et al. Among authors: weiser d. Arzneimittelforschung. 2000 May;50(5):415-9. doi: 10.1055/s-0031-1300225. Arzneimittelforschung. 2000. PMID: 10858868

5

Mechanisms involved in the anti-inflammatory effect of a standardized willow bark extract.

Khayyal MT, El-Ghazaly MA, Abdallah DM, Okpanyi SN, Kelber O, Weiser D. Khayyal MT, et al. Among authors: weiser d. Arzneimittelforschung. 2005;55(11):677-87. doi: 10.1055/s-0031-1296917. Arzneimittelforschung. 2005. PMID: 16366042

6

In vitro anti-proliferative effects of the willow bark extract STW 33-I.

Bonaterra GA, Kelber O, Weiser D, Metz J, Kinscherf R. Bonaterra GA, et al. Among authors: weiser d. Arzneimittelforschung. 2010;60(6):330-5. doi: 10.1055/s-0031-1296296. Arzneimittelforschung. 2010. PMID: 20648923

7

Reduction of high-affinity beta2-adrenergic receptor binding by hyperforin and hyperoside on rat C6 glioblastoma cells measured by fluorescence correlation spectroscopy.

Prenner L, Sieben A, Zeller K, Weiser D, Häberlein H. Prenner L, et al. Among authors: weiser d. Biochemistry. 2007 May 1;46(17):5106-13. doi: 10.1021/bi6025819. Epub 2007 Apr 7. Biochemistry. 2007. PMID: 17417877

8

Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.

Jakobs D, Hage-Hülsmann A, Prenner L, Kolb C, Weiser D, Häberlein H. Jakobs D, et al. Among authors: weiser d. J Pharm Pharmacol. 2013 Jun;65(6):907-15. doi: 10.1111/jphp.12050. Epub 2013 Mar 18. J Pharm Pharmacol. 2013. PMID: 23647684

9

Antioxidative properties of Iberis amara extracts in biochemical model reactions.

Schempp H, Toth A, Weiser D, Elstner EF. Schempp H, et al. Among authors: weiser d. Arzneimittelforschung. 2003;53(8):568-77. doi: 10.1055/s-0031-1297151. Arzneimittelforschung. 2003. PMID: 13677247

10

Biochemical model reactions indicative of inflammatory processes. Activities of extracts from Fraxinus excelsior and Populus tremula.

Schempp H, Weiser D, Elstner EF. Schempp H, et al. Among authors: weiser d. Arzneimittelforschung. 2000 Apr;50(4):362-72. doi: 10.1055/s-0031-1300215. Arzneimittelforschung. 2000. PMID: 10800635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters